Evaluation of the efficacy of Yinqiao Baiyi Decoction for asymptomatic patients infected with COVID-19
Not Applicable
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
- Registration Number
- ITMCTR2200006748
- Lead Sponsor
- The First Affiliated Hospital to Henan University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
? Asymptomatic patients with COVID-19;
? Age 18-80 years old;
? Voluntarily accept treatment and sign informed consent.
Exclusion Criteria
? delirious, consciousness disorder, dementia, all kinds of mental patients;
? Pregnant and lactating women;
? Patients with active pulmonary tuberculosis, pulmonary abscess and chronic respiratory failure;
? Patients with tumor;
? Patients with severe liver and kidney diseases;
? patients with severe cardiovascular and cerebrovascular diseases;
? those who are taking part in clinical trials of other drugs and are known to be allergic to the treatment drugs.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ucleic acid conversion rate;Nucleic acid turning negative time;
- Secondary Outcome Measures
Name Time Method Time to change to light/normal;Incidence of symptoms;Cumulative incidence of adverse events;rate to light/normal;